Vizgen

Innovative Spatial Biology Technology

Vizgen was founded in 2019, is headquartered in Cambridge, United States, lists 51–200 employees, and has $158.2M in recorded funding across 4 rounds.

Employees
51–200
Founded
2019
Business Model
B2B
Website
vizgen.com
Total Funding
$158.2M
Last Round
$85.2M Series CJun 2022
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Vizgen is redefining how scientists see and understand biology as a leader in spatial multiomics, delivering single-cell, spatially resolved data with AI-powered analysis for researchers, clinicians, and biopharma teams. Founded in 2019 to improve human health through spatial genomics, the company built on MERFISH technology exclusively licensed from Harvard University and launched the MERSCOPE platform to map RNA and protein molecules with subcellular precision. In 2024, Vizgen merged with Ultivue to combine single-cell spatial genomics with multiplex proteomic biomarker detection. More than 200 MERSCOPE platforms are installed globally, and Vizgen operates facilities in Cambridge and Waltham, Massachusetts.

Summary

Vizgen is a Biotech company based in Cambridge, United States, founded in 2019. It lists 51–200 employees. It has raised $158.2M in total across 4 rounds, most recently a $85.2M Series C round in Jun 2022. Investors include Northpond Ventures, Kenneth Chien / Novalis LifeSciences and ARCH Venture Partners.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CJun 2022
$85.2M

Sign up to see all 4 events

Funding: Seed through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vizgen on Indexed.vc
<a href="https://indexed.vc/companies/vizgen"><img src="https://indexed.vc/api/badge/company/vizgen" alt="Vizgen on Indexed.vc" width="260" height="76" /></a>